BMS-986263

DB28821InvestigationalProtein Based Therapies

BMS-986263 is a biologic drug. BMS-986263 is under investigation in clinical trial NCT04267393 (Safety and Effectiveness of BMS-986263 in Adults With Compensated Cirrhosis (Liver Disease) From Nonalcoholic Steatohepatitis (NASH)).

Mechanism: Pharmacologically active on Serpin H1
Curator reviewed
Code names: BMS-986263 · ND-L02-s0201

Resolves to

Targets

P50454SERPINH1

What you can answer from here — as of September 22, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

8Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with BMS-986263, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account